Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleORIGINAL ARTICLE

The Met852 Residue Is a Key Organizer of the Ligand-Binding Cavity of the Human Mineralocorticoid Receptor

Jérôme Fagart, Cendrine Seguin, Grégory Maurice Pinon and Marie-Edith Rafestin-Oblin
Molecular Pharmacology May 2005, 67 (5) 1714-1722; DOI: https://doi.org/10.1124/mol.104.010710
Jérôme Fagart
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cendrine Seguin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grégory Maurice Pinon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Edith Rafestin-Oblin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 67 no. 5 1714-1722
DOI 
https://doi.org/10.1124/mol.104.010710
PubMed 
15716462

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received December 22, 2004
  • Accepted February 16, 2005
  • Published online April 14, 2005.

Article Versions

  • Earlier version (February 16, 2005 - 12:44).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Jérôme Fagart,
  2. Cendrine Seguin,
  3. Grégory Maurice Pinon and
  4. Marie-Edith Rafestin-Oblin
  1. Institut National de la Santé et de la Recherche Médicale U478, Institut Fédératif de Recherche 02, Faculté de Médecine Xavier Bichat, Paris, France
  1. Address correspondence to:
    Dr. M. E. Rafestin-Oblin, Institut National de la Santé et de la Recherche Médicale U478, Faculté de Médecine Xavier Bichat; 16, rue Henri Huchard, 75870 Paris Cedex 18, France. E-mail: oblin{at}bichat.inserm.fr
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: February 2005 to March 2023

AbstractFullPdf
Feb 200523029
Mar 200521039
Apr 2005331240
May 2005204134
Jun 2005243523
Jul 200514357
Aug 2005112113
Sep 200531310
Oct 200521915
Nov 200517173
Dec 20057161
Jan 20061083
Feb 20061955
Mar 20061636
Apr 20068106
May 20065139
Jun 200691110
Jul 20067238
Aug 20063121
Sep 20065132
Oct 20065107
Nov 20061385
Dec 2006364
Jan 200771415
Feb 20071107
Mar 2007389
Apr 200792417
May 20073187
Jun 20074136
Jul 20074613
Aug 20075127
Sep 200731010
Oct 200751212
Nov 20078148
Dec 2007397
Jan 2008355
Feb 20086910
Mar 200810117
Apr 200812155
May 200817114
Jun 200814208
Jul 20081489
Aug 200881882
Sep 200826185
Oct 20081275
Nov 200821211
Dec 2008522
Jan 2009466
Feb 2009551
Mar 2009866
Apr 20092812
May 2009232
Jun 2009031
Jul 2009784
Aug 2009781
Sep 2009547
Oct 2009970
Nov 2009545
Dec 20091220
Jan 2010325
Feb 2010833
Mar 2010232
Apr 2010711
May 2010698
Jun 2010281
Jul 2010775
Aug 2010824
Sep 2010375
Oct 2010565
Nov 2010884
Dec 2010571
Jan 2011668
Feb 2011167
Mar 20116104
Apr 2011352
May 2011382
Jun 2011453
Jul 2011578
Aug 2011226
Sep 2011473
Oct 2011285
Nov 2011372
Dec 2011562
Jan 2012353
Feb 20121101
Mar 20126193
Apr 201221411
May 2012694
Jun 2012232
Jul 20121084
Aug 2012563
Sep 2012876
Oct 2012479
Nov 2012896
Dec 2012435
Jan 2013635
Feb 2013642
Mar 2013774
Apr 2013655
May 2013258
Jun 2013144
Jul 2013243
Aug 2013622
Sep 20131224
Oct 2013140
Nov 2013200
Dec 2013552
Jan 2014914
Feb 2014487
Mar 20143119
Apr 2014111110
May 201481518
Jun 2014874
Jul 2014342
Aug 2014220
Sep 2014784
Oct 2014732
Nov 20141173
Dec 20146675
Jan 20152184
Feb 2015061
Mar 2015512
Apr 2015547
May 2015433
Jun 2015674
Jul 2015151010
Aug 201518136
Sep 20151033
Oct 2015711
Nov 2015744
Dec 2015602
Jan 20161327
Feb 2016365
Mar 201611311
Apr 2016448
May 2016029
Jun 2016325
Jul 2016425
Aug 2016111
Sep 2016142
Oct 2016152
Nov 2016123
Dec 2016423
Jan 2017040
Feb 20171128
Mar 2017021
Apr 2017052
May 20170173
Jun 20170115
Jul 20170810
Aug 20173114
Sep 20172101
Oct 20171101
Nov 20170185
Dec 20170123
Jan 20180120
Feb 2018062
Mar 20180111
Apr 201802185
May 20180551
Jun 20180822
Jul 201825511
Aug 20180121
Sep 2018089
Oct 20180257
Nov 20180475
Dec 20182972
Jan 20193213
Feb 20192301
Mar 20192202
Apr 2019512
May 2019703
Jun 2019504
Jul 20191312
Aug 20191702
Sep 20192310
Oct 20191111
Nov 20191301
Dec 2019900
Jan 2020400
Feb 2020912
Mar 2020600
Apr 2020511
May 2020900
Jun 2020701
Jul 20201901
Aug 2020201
Sep 2020210
Oct 2020800
Nov 2020300
Dec 2020512
Jan 20211434
Feb 2021822
Mar 20211220
Apr 20211310
May 20211021
Jun 2021510
Jul 20211412
Aug 20211134
Sep 20211020
Oct 20211210
Nov 20211512
Dec 20211310
Jan 20221500
Feb 2022611
Mar 2022310
Apr 20221530
May 2022421
Jun 20221100
Jul 2022711
Aug 2022722
Sep 2022900
Oct 20221211
Nov 20221531
Dec 2022310
Jan 2023832
Feb 20231510
Mar 20231012

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 67 (5)
Molecular Pharmacology
Vol. 67, Issue 5
1 May 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Met852 Residue Is a Key Organizer of the Ligand-Binding Cavity of the Human Mineralocorticoid Receptor
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleORIGINAL ARTICLE

The Met852 Residue Is a Key Organizer of the Ligand-Binding Cavity of the Human Mineralocorticoid Receptor

Jérôme Fagart, Cendrine Seguin, Grégory Maurice Pinon and Marie-Edith Rafestin-Oblin
Molecular Pharmacology May 1, 2005, 67 (5) 1714-1722; DOI: https://doi.org/10.1124/mol.104.010710

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleORIGINAL ARTICLE

The Met852 Residue Is a Key Organizer of the Ligand-Binding Cavity of the Human Mineralocorticoid Receptor

Jérôme Fagart, Cendrine Seguin, Grégory Maurice Pinon and Marie-Edith Rafestin-Oblin
Molecular Pharmacology May 1, 2005, 67 (5) 1714-1722; DOI: https://doi.org/10.1124/mol.104.010710
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The 73-kDa Heat Shock Cognate Protein Is a CXCR4 Binding Protein that Regulates the Receptor Endocytosis and the Receptor-Mediated Chemotaxis
  • Endogenous Regulator of G-Protein Signaling Proteins Regulate the Kinetics of Gαq/11-Mediated Modulation of Ion Channels in Central Nervous System Neurons
  • A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling
Show more ORIGINAL ARTICLE

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics